Earth Science Tech Past Earnings Performance
Past criteria checks 2/6
Earth Science Tech has been growing earnings at an average annual rate of 40.2%, while the Pharmaceuticals industry saw earnings growing at 1% annually. Revenues have been growing at an average rate of 36.4% per year. Earth Science Tech's return on equity is 15.3%, and it has net margins of 5.5%.
Key information
40.2%
Earnings growth rate
41.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 36.4% |
| Return on equity | 15.3% |
| Net Margin | 5.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Earth Science Tech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6 | 0 | 4 | 0 |
| 30 Sep 23 | 2 | 0 | 2 | 0 |
| 30 Jun 23 | 0 | 0 | 1 | 0 |
| 31 Mar 23 | 0 | 0 | 1 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
| 30 Sep 22 | 0 | 0 | 0 | 0 |
| 30 Jun 22 | 0 | 3 | 0 | 0 |
| 31 Mar 22 | 0 | 3 | 0 | 0 |
| 31 Dec 21 | 0 | 3 | 0 | 0 |
| 30 Sep 21 | 0 | 3 | 0 | 0 |
| 30 Jun 21 | 0 | -1 | 0 | 0 |
| 31 Mar 21 | 0 | -4 | 0 | 0 |
| 31 Dec 20 | 0 | -4 | 1 | 0 |
| 30 Sep 20 | 0 | -4 | 1 | 0 |
| 30 Jun 20 | 0 | -5 | 1 | 0 |
| 31 Mar 20 | 1 | -1 | 1 | 0 |
| 31 Dec 19 | 1 | -2 | 1 | 0 |
| 30 Sep 19 | 1 | -2 | 1 | 0 |
| 30 Jun 19 | 1 | -2 | 2 | 0 |
| 31 Mar 19 | 1 | -2 | 2 | 0 |
| 31 Dec 18 | 1 | -2 | 2 | 0 |
| 30 Sep 18 | 1 | -2 | 2 | 0 |
| 30 Jun 18 | 1 | -2 | 2 | 0 |
| 31 Mar 18 | 0 | -2 | 2 | 0 |
| 31 Dec 17 | 0 | -2 | 2 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | 0 | 1 | 0 |
| 31 Mar 16 | 0 | -1 | 1 | 0 |
| 31 Dec 15 | 0 | -2 | 1 | 0 |
| 30 Sep 15 | 0 | -9 | 9 | 0 |
| 30 Jun 15 | 0 | -9 | 9 | 0 |
| 31 Mar 15 | 0 | -9 | 9 | 0 |
| 31 Dec 14 | 0 | -21 | 21 | 0 |
| 30 Sep 14 | 0 | -13 | 13 | 0 |
| 30 Jun 14 | 0 | -13 | 13 | 0 |
| 31 Mar 14 | 0 | -13 | 13 | 0 |
| 31 Dec 13 | 0 | 0 | 0 | 0 |
| 30 Sep 13 | 0 | 0 | 0 | 0 |
| 30 Jun 13 | 0 | 0 | 0 | 0 |
Quality Earnings: ETST has a large one-off gain of $531.2K impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: ETST became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ETST has become profitable over the past 5 years, growing earnings by 40.2% per year.
Accelerating Growth: ETST has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ETST has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-13.2%).
Return on Equity
High ROE: ETST's Return on Equity (15.3%) is considered low.